IBMM, Univ Montpellier, CNRS, ENSCM, 34095 Montpellier, France.
Department of Physics and Astronomy, Soft-Matter Physics and Biophysics Section, KU Leuven, Celestijnenlaan 200D, Box 2416, 3001 Heverlee, Belgium.
ACS Chem Neurosci. 2022 Mar 16;13(6):786-795. doi: 10.1021/acschemneuro.1c00784. Epub 2022 Feb 24.
Aggregation of amyloid β peptides is known to be one of the main processes responsible for Alzheimer's disease. The resulting dementia is believed to be due in part to the formation of potentially toxic oligomers. However, the study of such intermediates and the understanding of how they form are very challenging because they are heterogeneous and transient in nature. Unfortunately, few techniques can quantify, in real time, the proportion and the size of the different soluble species during the aggregation process. In a previous work (Deleanu et al 2021, 93, 6523-6533), we showed the potential of Taylor dispersion analysis (TDA) in amyloid speciation during the aggregation process of Aβ (1-40) and Aβ (1-42). The current work aims at exploring in detail the aggregation of amyloid Aβ (1-40):Aβ (1-42) peptide mixtures with different proportions of each peptide (1:0, 3:1, 1:1, 1:3, and 0:1) using TDA and atomic force microscopy (AFM). TDA allowed for monitoring the kinetics of the amyloid assembly and quantifying the transient intermediates. Complementarily, AFM allowed the formation of insoluble fibrils to be visualized. Together, the two techniques enabled us to study the influence of the peptide ratios on the kinetics and the formation of potentially toxic oligomeric species.
淀粉样β肽的聚集被认为是导致阿尔茨海默病的主要过程之一。由此产生的痴呆症部分归因于潜在毒性寡聚物的形成。然而,研究这些中间体以及了解它们如何形成是非常具有挑战性的,因为它们在性质上是异质的和瞬态的。不幸的是,很少有技术可以实时定量聚合过程中不同可溶性物种的比例和大小。在之前的工作(Deleanu 等人,2021 年,93,6523-6533)中,我们展示了泰勒分散分析(TDA)在 Aβ(1-40)和 Aβ(1-42)聚合过程中淀粉样蛋白分类中的潜力。目前的工作旨在使用 TDA 和原子力显微镜(AFM)详细研究淀粉样 Aβ(1-40):Aβ(1-42)肽混合物的聚合,其中每种肽的比例不同(1:0、3:1、1:1、1:3 和 0:1)。TDA 允许监测淀粉样蛋白组装的动力学并定量瞬态中间体。此外,AFM 允许可视化不溶性原纤维的形成。这两种技术一起使我们能够研究肽比例对动力学和潜在毒性寡聚物形成的影响。